Technologies to: 1-Treat the progression of age-related macular degeneration (AMD) and retinitis pigmentosa (RP), 2-Stop/reverse some of the vision loss from Glaucoma, 3-Prevent diabetic retinopathy, 4-Greatly enhance pars plana vitrectomy surgery
Start Trial Get Full Profile
There’s no risk. Start your trial today to see profiles of VitreoRetinal Technologies (aka VRT) plus 4808 other startups.